Antidepressant drug effects and depression severity: a patient-level meta-analysis - Test2 - elhamkhani - TriplyDB

Antidepressant drug effects and depression severity: a patient-level meta-analysis

Antidepressant drug effects and depression severity: a patient-level meta-analysis

http://www.wikidata.org/entity/Q24598580

about

A systematic review of comparative efficacy of treatments and controls for depression Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis A Review of Longitudinal Electroconvulsive Therapy: Neuroimaging Investigations Change in mental health after smoking cessation: systematic review and meta-analysis Omega-3 fatty acids for depression in adults Mirtazapine (adjunct) versus placebo for schizophrenia Antidepressant treatment for postnatal depression Agomelatine versus other antidepressive agents for major depression Alprazolam for depression Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression Psychological and pharmacological interventions for depression in patients with coronary artery disease Agomelatine versus other antidepressive agents for major depression Which placebo to cure depression? A thought-provoking network meta-analysis Project INTEGRATE: An integrative study of brief alcohol interventions for college students Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis The Efficacy of Mindfulness-Based Interventions in Primary Care: A Meta-Analytic Review Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis Pharmacological treatment of anxiety disorders: current treatments and future directions Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?Cognitive mechanisms of treatment in depression The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond Peripartum depression and anxiety as an integrative cross domain target for psychiatric preventative measures Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish.The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy Assessment of cognitive safety in clinical drug development Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline Meditation programs for psychological stress and well-being: a systematic review and meta-analysis Antidepressants and the Placebo Effect Lessons learned from placebo groups in antidepressant trials Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales Accounting for Behavior in Treatment Effects: New Applications for Blind Trials

P2860

Q21134116-0CAFA1DF-EFD1-41F2-9E41-E1A006A47164 Q22241534-D44FD74B-C808-4C69-B50D-66D5C84F6A4A Q22299257-B371BE42-32D2-4313-A30B-84A365D765B8 Q22306548-2BCBA8DB-245D-4B38-AE76-36F2B3738DB9 Q24187951-5D89775D-FE84-4126-82F8-F5A7CCA9A45C Q24188248-235F6E42-39A8-4EEA-AD9F-B773512E999B Q24193660-890A273E-D719-4514-AA58-0AACD691D073 Q24201746-B514D8B0-780C-4EE6-9C49-6BE684D6B359 Q24201994-10DBE5D8-33BB-43E2-AC91-2F7AA2491641 Q24202387-5266BD3F-35A1-47A4-8AC4-FB8F941B9486 Q24234331-C0B6B150-3002-40C1-898F-D82863D18B38 Q24234339-7ED13FE7-CEF8-4EE9-BA38-F37C130A9C9B Q24288940-68703A7F-6655-480E-96A6-44592621D118 Q24289365-76C4EFFA-947A-4405-9C6A-478781118A82 Q24601815-18B077F7-2B96-437F-B15B-8F4E0DBC9F3D Q24607720-21CBC5BF-6AD7-4451-87DC-4D78BAB1B84C Q24634019-CFDDFA9A-DE75-4569-A322-AE1468FA8F3E Q26778254-57916295-2BA3-4F01-A3E2-2D031C2899EC Q26779632-EB4D9E62-452D-4DBD-AA79-B376AD2F7467 Q26851461-C6CBAAC6-5C0A-4D1E-9683-103517E37024 Q26996411-5B4699F3-8B44-45F4-B09A-4706373BAF99 Q27001088-C4E1A6A4-5AA0-4CE6-93B9-40EB3FD02EE7 Q27010327-8D187A35-7D65-4326-AA8E-2B1D2967434A Q27015195-CB47E198-28D3-4998-8236-B06C28A1D23D Q27022217-F6D3E117-D5B4-4AF0-848D-F9611E837878 Q27023402-871A2459-DF14-4C06-8AEC-B368F9A01D3B Q27308009-B419A167-C2E7-486C-8783-FA5BF1E09B75 Q27324499-A911BBDD-C203-44B0-8D18-2D61C6C40C53 Q28082434-80F5110E-EC7A-46E1-9970-7BF18614809F Q28083651-AEC6C607-4C13-46CD-803C-1E79B5BAEB9D Q28084637-4A2C83D9-90F4-4C28-B29D-3F219BF95BD1 Q28246147-10970C3E-3297-49A0-AE93-3252508FFDEE Q28286878-2228C015-36FB-45F3-BC4B-83D395FC30E5 Q28305336-77B8A2A2-F9C3-4303-88E9-C92E479BDA13 Q28468667-BAC255AD-BF62-4085-8C27-93954107BF99 Q28478927-3741A320-3171-4908-A200-0E5E0AB79722 Q28481584-F476BCD4-3D12-47DA-B935-869A61F588BB Q28487260-1BAC93CB-E08F-4F78-BF50-86FBB801C3E8 Q28542596-EAA7577E-FAFB-4112-AF54-269F602C6FAB Q28548112-9C839F86-3C80-4C93-9ECC-31A3F48AC06F

P2860

Antidepressant drug effects and depression severity: a patient-level meta-analysis

http://www.wikidata.org/entity/Q24598580

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@ast

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@en

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@nl

type

label

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@ast

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@en

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@nl

prefLabel

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@ast

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@en

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@nl

P1433

Q24598580-DE72E136-F1D8-4109-8A41-A6BD7A18B06C

P1476

Q24598580-A94A90BD-0EAF-4FBF-9F54-20AF87D2DD67

P2093

Q24598580-22BDCC4D-233B-4DDD-BFF2-561EC94559A4

Q24598580-4A0E480F-77CB-4439-8A90-F6D88F943736

Q24598580-939A2FC0-2ED2-4453-9682-3AF6AAFC221E

Q24598580-A0ACAB55-2221-4337-AA4F-D50BA0BD6A0B

Q24598580-D38BAD37-FF3F-436A-B7FE-0216237FC8D2

P2860

Q24598580-031A4EE6-F13D-4391-9561-6C1CCFE9C8FF

Q24598580-0DC8D316-EB4D-4AEA-9E76-73A0DB5E4740

Q24598580-1424289B-585A-4E52-82B8-F79D78E95EF4

Q24598580-16584D62-EC0E-4F98-ACD3-39EACC5326EC

Q24598580-1AC43B10-977F-4E2D-BB73-1BF5DC130072

Q24598580-340DCB05-ACE8-4781-88FB-900B38963679

Q24598580-382B7DDC-E153-45CA-B056-A626A6EC53FA

Q24598580-3D0BAD67-8577-4CA3-81C0-6163D4F6179D

Q24598580-3FF34C83-FE64-4605-91FA-4F65ECD3BF6E

Q24598580-462A7448-B026-4506-A2BD-A5179DBF0C6B

P304

Q24598580-DAC864E0-49F4-4523-ABB9-48BE0AFAA78C

P31

Q24598580-1ED063B4-024C-4165-B28B-CCC9E5CA5783

Q24598580-E0B9BEB6-59A4-412A-B417-63179AB6FF5A

P3181

Q24598580-E74B8799-36C9-4EB7-8912-246572AF375D

P356

Q24598580-BC088190-EDAC-4985-85AB-CE45A0E7BC50

P407

Q24598580-F79ED6A1-AE32-45CB-942D-0EA1FF7FC9DD

P433

Q24598580-FF069686-5310-4E11-950A-C7E255716FF3

P478

Q24598580-26743BEA-2BC8-4697-B62E-AE72D11A4C2A

P50

Q24598580-524E7F58-7AC6-4D47-BF65-341AEB7FAB9D

Q24598580-BD2E54DC-30B3-4F2D-BE7C-B76F6A8A2823

P577

Q24598580-83B7F1ED-C0BE-4490-9F78-4F6DD45F68DC

P5875

Q24598580-817C7BB9-1004-4936-950E-EF72E5DCFAE3

P698

Q24598580-29953226-0955-4E6C-93FB-01C3A3B87CA6

P921

Q24598580-464951A6-03AD-433F-9712-2FB6CFACA4BE

Q24598580-7F72A2A5-1983-47C6-A863-74400E7CDAE8

P932

Q24598580-3A0F3E7B-403C-49FC-BDFC-BD162635EB17

P3181

P356

P1433

Journal of the American Medical Association

P1476

Antidepressant drug effects and depression severity: a patient-level meta-analysis

@en

P2093

Jan Fawcett

http://www.w3.org/2001/XMLSchema#string

Jay D Amsterdam

http://www.w3.org/2001/XMLSchema#string

Richard C Shelton

http://www.w3.org/2001/XMLSchema#string

Sona Dimidjian

http://www.w3.org/2001/XMLSchema#string

Steven D Hollon

http://www.w3.org/2001/XMLSchema#string

P2860

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

A rating scale for depression

Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression

Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression

The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

National Institute of Mental Health Treatment of Depression Collaborative Research Program

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.

The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.

Acute and maintenance treatment of chronic depression.

P304

47-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

826213

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2009.1943

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

303

http://www.w3.org/2001/XMLSchema#string

P50

Robert J. DeRubeis

Jay C. Fournier

P577

2010-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40850405

http://www.w3.org/2001/XMLSchema#string

P698

20051569

http://www.w3.org/2001/XMLSchema#string

P921

P932

3712503

http://www.w3.org/2001/XMLSchema#string